Teva Pharmaceutical Industries Limited
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $24.31B | $54.23B | $6.95B |
| FY2016 | $58.06B | $93.06B | $6.95B |
| FY2017 | $51.87B | $70.62B | $963.0M |
| FY2018 | $44.89B | $60.68B | $1.78B |
| FY2019 | $42.41B | $57.47B | $1.98B |
| FY2020 | $39.58B | $50.64B | $2.18B |
| FY2021 | $36.42B | $47.67B | $2.17B |
| FY2022 | $36.12B | $45.93B | $2.80B |
| FY2023 | $34.96B | $43.46B | $3.23B |
| FY2024 | $33.61B | $39.33B | $3.30B |